ASSEMBLY AND EXTRACELLULAR RELEASE OF CHIMERIC HIV-1 PR55(GAG) RETROVIRUS-LIKE PARTICLES

被引:55
作者
WAGNER, R
DEML, L
FLIESSBACH, H
WANNER, G
WOLF, H
机构
[1] INST MED MIKROBIOL,W-8400 REGENSBURG,GERMANY
[2] LMU MUNCHEN,INST BOT,MUNICH,GERMANY
关键词
D O I
10.1006/viro.1994.1175
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HIV-1 Pr55(gag) precursors were previously shown to assemble and bud from a variety of different cell types as noninfectious virus-like particles (VLPs) resembling immature HIV virions. The use of these VLPs as an immunogenic and autologous carrier component may allow the presentation of defined epitopes deduced from reading frames other than gag to the immune system, thereby avoiding the induction of adverse immune responses. In order to identify domains within Pr55(gag) that can be replaced by immunologically relevant epitopes without affecting its capacity to assemble into VLPs, we deleted three domains of a predicted high surface probability. Deletion of amino acids 211-241 within p24CA and amino acids 436-471 within the p6LI portion of Pr55(gag) had no effect on the assembly, ultrastructure, biophysical properties, and yields of mutant VLPs when expressed via recombinant vaccinia viruses in mammalian cells. Deletion of amino acids 99-154 overlapping the p17MA/p24CA cleavage site completely abolished the capacity of the gag polyprotein to form VLPs and led to a reduction of immature Pr55 VLPs released into the cell-culture supernatants when coexpressed with wild-type Pr55(gag). In contrast, assembly and budding of chimeric VLPs could be demonstrated after replacing amino acids 211-241 and 436-471 by immunologically relevant epitopes derived from reading frames other than pr55(gag) (e.g., vs loop; CD4-binding-domain; nef-CTL epitope) or after fusion of these sequences to the carboxy terminus of Pr55(gag). The importance of these data for the development of novel HIV candidate vaccines is discussed. (C) 1994 Academic Press, Inc.
引用
收藏
页码:162 / 175
页数:14
相关论文
共 59 条
  • [1] B-CELL ACTIVATION AND HIV-1 INFECTION - DEEDS AND MISDEEDS
    AMADORI, A
    CHIECOBIANCHI, L
    [J]. IMMUNOLOGY TODAY, 1990, 11 (10): : 374 - 379
  • [2] AMADORI A, 1992, J IMMUNOL, V148, P2709
  • [3] BLACKBURN R, 1991, ADV EXP MED BIOL, V303, P63
  • [4] RELATION BETWEEN HUMORAL RESPONSES TO HIV GAG AND ENV PROTEINS AT SEROCONVERSION AND CLINICAL OUTCOME OF HIV-INFECTION
    CHEINGSONGPOPOV, R
    PANAGIOTIDI, C
    BOWCOCK, S
    ARONSTAM, A
    WADSWORTH, J
    WEBER, J
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1991, 302 (6767): : 23 - 26
  • [5] AN ANTIGENIC PEPTIDE OF THE HIV-1 NEF PROTEIN RECOGNIZED BY CYTOTOXIC LYMPHOCYTE-T OF SEROPOSITIVE INDIVIDUALS IN ASSOCIATION WITH DIFFERENT HLA-B MOLECULES
    CULMANN, B
    GOMARD, E
    KIENY, MP
    GUY, B
    DREYFUS, F
    SAIMOT, AG
    SERENI, D
    LEVY, JP
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1989, 19 (12) : 2383 - 2386
  • [6] MORPHOGENESIS AND MORPHOLOGY OF HIV - STRUCTURE-FUNCTION RELATIONS
    GELDERBLOM, HR
    OZEL, M
    PAULI, G
    [J]. ARCHIVES OF VIROLOGY, 1989, 106 (1-2) : 1 - 13
  • [7] ASSEMBLY AND RELEASE OF HIV-1 PRECURSOR PR55GAG VIRUS-LIKE PARTICLES FROM RECOMBINANT BACULOVIRUS INFECTED INSECT CELLS
    GHEYSEN, D
    JACOBS, E
    DEFORESTA, F
    THIRIART, C
    FRANCOTTE, M
    THINES, D
    DEWILDE, M
    [J]. CELL, 1989, 59 (01) : 103 - 112
  • [8] GOETTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781
  • [9] GOETTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195
  • [10] COMMON EPITOPE IN HUMAN IMMUNODEFICIENCY VIRUS (HIV) I-GP41 AND HLA CLASS-II ELICITS IMMUNOSUPPRESSIVE AUTOANTIBODIES CAPABLE OF CONTRIBUTING TO IMMUNE DYSFUNCTION IN HIV I-INFECTED INDIVIDUALS
    GOLDING, H
    SHEARER, GM
    HILLMAN, K
    LUCAS, P
    MANISCHEWITZ, J
    ZAJAC, RA
    CLERICI, M
    GRESS, RE
    BOSWELL, RN
    GOLDING, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) : 1430 - 1435